MedTrace Logo

Cell Therapy In Dilated Cardiomyopathy

NCT00333827 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 115

Last updated 2017-03-13

No results posted yet for this study

Summary

The purpose of this study is to determine effect of cell therapy in patients with severe dilated cardiomyopathy

Conditions

  • Dilated Cardiomyopathy

Interventions

DRUG

optimal therapy for cardiaca failure

optimal therapy for cardiaca failure

PROCEDURE

cell

stem cell

Sponsors & Collaborators

  • Financiadora de Estudos e Projetos

    collaborator OTHER

  • Ministry of Health, Brazil

    lead OTHER_GOV

Principal Investigators

  • Antonio Carlos C de Carvalho, MD,PhD · INCL

  • Bernardo R Tura, Md,MsC · INCL

  • Augusto Z Bozza, MD · INCL

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-01-31
Primary Completion
2012-12-31
Completion
2013-02-28

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00333827 on ClinicalTrials.gov